Actinium raises $5.1M ahead of reverse-merger

Actinium Pharmaceuticals Inc. (Newark, N.J.) raised $5.1 million through the sale of about 9.3 million

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE